Daniel J. Lenihan, MD
Daniel J. Lenihan, MD, is one of the Founders and a current Board Member of the International Cardio-Oncology Society. For more than 20 years, he has been committed to improving the cardiovascular care of patients who are receiving treatment for cancer and optimally treating underlying heart disease for those who have survived cancer therapy. He has extensive clinical and research experience in the best treatment and identification of patients at risk for heart failure and other cardiovascular diseases during and after cancer therapy. In combination with Carlo Cipolla, MD in Milan, Italy, and Eric Harrison, MD, in Tampa, Florida, he founded the International Cardio-Oncology Society in 2009. He has personally initiated and fully developed Cardio-Oncology clinical and research programs at several major institutions over the past 20 years. In addition, he has extensive experience in detecting cardiac related toxicity and adverse events during cancer therapy in disciplined clinical research with many presentations and meetings conducted at the major research and regulatory agencies throughout the world. He has a great personal interest and commitment to enhancing education, research and therapeutic options in patients who have amyloidosis. He is an active board member for the non-profit Amyloidosis Foundation.